A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus
NCT00367445 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2008-01-29
Summary
To compare short-term efficacy and safety of Exubera vs Lantus in patients with type 2 diabetes mellitus
Conditions
- Diabetes Mellitus, Type 2
Interventions
- DRUG
-
Inhaled Human Insulin (Exubera)
- DRUG
-
Insulin Glargine (Lantus)
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-09-30
- Completion
- 2007-02-28
Countries
- United States
Study Locations
More Related Trials
-
A Clinical Trial Comparing The Efficacy And Safety Of 2 Different Initial Dose Prescriptions For Exubera.
NCT00437489 ·Status: TERMINATED ·Phase: PHASE4
-
Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety
NCT00359801 ·Status: COMPLETED ·Phase: PHASE4
-
A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD
NCT00138671 ·Status: TERMINATED ·Phase: PHASE3
-
A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus
NCT00282971 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 2 Diabetes
NCT00136916 ·Status: TERMINATED ·Phase: PHASE3
-
Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus
NCT00143247 ·Status: TERMINATED ·Phase: PHASE2
-
A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control
NCT00134147 ·Status: COMPLETED ·Phase: PHASE3
-
Safety And Efficacy Of Exubera Compared With Subcutaneous Human Insulin Therapy In Children And Adolescents
NCT00479258 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 1 Diabetes
NCT00137046 ·Status: TERMINATED ·Phase: PHASE3
-
US Inhaled Insulin Dose Titration Study
NCT00246623 ·Status: COMPLETED ·Phase: PHASE3
-
Effect on Glycemic Control of Inhaled Insulin Alone or Added to Dual Oral Therapy After Failure of Dual Oral Therapy.
NCT00370565 ·Status: COMPLETED ·Phase: PHASE3
-
A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With Asthma
NCT00139659 ·Status: COMPLETED ·Phase: PHASE3
-
Patient Transitioning From Exubera® Inhalation Powder to Technosphere® Insulin Inhalation Powder
NCT01798914 ·Status: NO_LONGER_AVAILABLE
-
Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling Glucose
NCT00150410 ·Status: COMPLETED ·Phase: PHASE3
-
Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 1 Diabetes Mellitus.
NCT00424437 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes
NCT00353834 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Short-Term Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients
NCT01270191 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy
NCT05463744 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
NCT02119819 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Estimate the Effects of Inhaled Versus Intravenous (IV) Infusion of Human Insulin in Subjects With Type 1 Diabetes
NCT00315952 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes
NCT00332488 ·Status: COMPLETED ·Phase: PHASE3
-
To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.
NCT00143338 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 Diabetes
NCT04569994 ·Status: COMPLETED ·Phase: PHASE1
-
Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes
NCT00103935 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Intranasal Insulin in Children and Young Adults at Risk of Type 1 Diabetes
NCT00336674 ·Status: COMPLETED ·Phase: PHASE2